Departments of Cardiac Surgery (B.Y., C.M.R., K.M.K., X.W., H.J.P., G.M.D.), Michigan Medicine, Ann Arbor.
Creighton University School of Medicine, Omaha, NE (E.L.N.).
Circulation. 2018 Nov 6;138(19):2091-2103. doi: 10.1161/CIRCULATIONAHA.118.036328.
Immediate open repair of acute type A aortic dissection is traditionally recommended to prevent death from aortic rupture. However, organ failure because of malperfusion syndrome (MPS) might be the most imminent life-threatening problem for a subset of patients.
From 1996 to 2017, among 597 patients with acute type A aortic dissection, 135 patients with MPS were treated with upfront endovascular reperfusion (fenestration/stenting) followed by delayed open repair (OR). We compared outcomes between the first and second decades and observed mortalities with those expected with an "upfront OR for every patient" approach, determined using prognostic models from the literature (Verona, Leipzig-Halifax, Stockholm, Penn, and GERAADA [German Registry for Acute Aortic Dissection Type A] models).
Overall, in-hospital mortality improved between the 2 decades (21.0% versus 10.7%, P<0.001). In the second decade, for patients with MPS initially treated with fenestration/stenting, mortality from aortic rupture decreased from 16% to 4% ( P=0.05), the risk of dying from organ failure was 6.6 times higher than dying from aortic rupture (hazard ratio=6.63; 95% CI, 1.5-29; P=0.01), and 30-day mortality after OR for MPS patients was 3.7%. Compared to the expected mortalities with the upfront OR for every patient models, our observed 30-day and in-hospital mortalities (9% and 11%, respectively) of all patients with acute type A aortic dissection were significantly lower ( P≤0.03).
Immediate OR is the strategy to prevent death from aortic rupture for the majority of patients with acute type A aortic dissection. However, relatively stable (no rupture, no tamponade) patients with MPS benefit from a staged approach: upfront endovascular reperfusion followed by aortic OR at resolution of organ failure.
传统上建议对急性 A 型主动脉夹层患者进行即刻开放修复,以防止主动脉破裂导致的死亡。然而,对于一部分患者而言,由灌注不良综合征(MPS)引起的器官衰竭可能是最具威胁生命的即刻问题。
1996 年至 2017 年,在 597 例急性 A 型主动脉夹层患者中,有 135 例 MPS 患者接受了早期血管内再灌注(开窗/支架置入)治疗,随后行延迟性开放修复(OR)。我们比较了两个十年间的结局,并观察了与“对每位患者均行早期 OR”方法预计的死亡率,该方法使用了文献中的预后模型(Verona、Leipzig-Halifax、Stockholm、Penn 和 GERAADA[德国 A 型急性主动脉夹层登记处]模型)来确定。
总体而言,两个十年间院内死亡率均有所改善(21.0%比 10.7%,P<0.001)。在第二个十年,对于最初接受开窗/支架置入治疗的 MPS 患者,主动脉破裂死亡率从 16%降至 4%(P=0.05),器官衰竭相关死亡风险是主动脉破裂相关死亡风险的 6.6 倍(风险比=6.63;95%可信区间,1.5-29;P=0.01),MPS 患者 OR 后 30 天死亡率为 3.7%。与对每位患者均行早期 OR 的模型相比,我们观察到所有急性 A 型主动脉夹层患者的 30 天和院内死亡率(分别为 9%和 11%)均显著降低(P≤0.03)。
对于大多数急性 A 型主动脉夹层患者,立即进行 OR 是预防主动脉破裂死亡的策略。然而,对于相对稳定(无破裂,无心脏压塞)的 MPS 患者,分期治疗(早期血管内再灌注,随后在器官衰竭缓解时行主动脉 OR)有益。